FIELD: medicine.
SUBSTANCE: invention refers to the compound of the formula (I) 
, where R1 is a group of the formula 
and
, in which R2, R3, R4, R5, R6, R7 and R8, each one independently represents a hydrogen atom or C1-6alkyl or its salt, to the method of its producing, to the method of antagonist effect on angiotensin II in the mammal, to the application of compounds of formula (I) as well as to methods of diseases prevention or treatment.
EFFECT: there are produced and provided new compounds that can be applied for prevention or treatment of disturbed circulation.
16 cl, 2 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZIMIDAZOLE DERIVATIVE AND USE AS ANGIOTENSIN II ANTAGONIST | 2006 |
|
RU2407742C2 |
| COMBINATION CONTAINING A COMPOUND OF ANGIOTENSIN II-ANTAGONISTIC ACTIVITY | 1997 |
|
RU2188013C2 |
| HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO ANGIOTENSIN-II AND A METHOD OF ANTAGONIZATION OF ANGIOTENSIN-II IN MAMMALS | 1992 |
|
RU2104276C1 |
| SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS | 2006 |
|
RU2422446C2 |
| CONDENSED CYCLIC COMPOUNDS | 2007 |
|
RU2444521C2 |
| NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE | 2010 |
|
RU2567755C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS, TREATMENT OR INHIBITION OF DEVELOPMENT OF SIMPLE RETINOPATHY AND PREPROLIFERATING RETINOPATHY | 2000 |
|
RU2239454C2 |
| HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF ANTAGONISM OF ANGIOTENSIN-II | 1992 |
|
RU2168510C2 |
| PHENYLACETIC ACID DERIVATIVE AND ITS USE | 2004 |
|
RU2349587C2 |
| DERIVATIVES OF INDANE ACETIC ACID AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2314298C2 |
